Investigational Drug Study for Adolescents and Adults with Fragile X Syndrome

Image

What are we studying?

The purpose of the study is to evaluate whether an investigational drug is safe and effective for the treatment of symptoms of Fragile X Syndrome.

Who can participate?

Males between 14 and 40 years of age who have a diagnosis of Fragile X Syndrome.  Participants need to exhibit behaviors such as repetitive or stereotyped behaviors, anxiety, social withdrawal, sensory over-sensitivity, or cognitive difficulties.

How will participants be compensated?

A small payment will be offered to offset travel expenses.

For more information, contact CANDI at 774-455-4100 or ChildResearch@umassmed.edu.

A PDF flyer is available for this study.

Docket # H-00003719

LogoInvesting in the future...helping kids and families.